InsiderTrades

Form 4 for CRSP CRISPR Therapeutics AG

Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-14 · accession 0001209191-22-053989 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-18 2022-10-17 CRSP Smith Brendan CFO F - Tax $55.76 -1,111 2,639 -30% -$61.9K
D 2022-10-18 2022-10-14 CRSP Smith Brendan CFO M - OptEx — +3,750 3,750 New —
D 2022-10-18 2022-10-14 CRSP Smith Brendan CFO M - OptEx — +3,750 11.2K +50% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2022-10-17 F D 1,111 $55.76 2,639 D — —
2 Common Common Shares 2022-10-14 M A 3,750 — 3,750 D — — (F1) The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025. (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
3 Derivative Restricted Stock Units 2022-10-14 M A 3,750 — 11,250 D — · — to — 3,750 Common Shares (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F1) The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025.